Pengana freezes redemptions at fund over Opthea
MELBOURNE: The failure of Opthea’s much-heralded eye treatment has already caused considerable pain for investors.
MELBOURNE: The failure of Opthea’s much-heralded eye treatment has already caused considerable pain for investors.